Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process

Balázs Koscsó1, Balázs Csóka, Zsolt Selmeczy

  • 1Department of Surgery, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.

Insights

Adenosine boosts anti-inflammatory IL-10 production in activated microglia via the A(2B) adenosine receptor (AR). This mechanism involves CREB activation and p38 MAPK signaling, while suppressing proinflammatory cytokines.

Area of Science:

  • Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Microglia, the immune cells of the central nervous system, produce pro-inflammatory and anti-inflammatory cytokines.
  • Adenosine receptors (ARs) are known to modulate microglial pro-inflammatory cytokine production.
  • The role of ARs in regulating the anti-inflammatory cytokine IL-10 in microglia remains uncharacterized.

Purpose of the Study:

  • To investigate the effect of adenosine on IL-10 production in activated murine microglia.
  • To identify the specific adenosine receptor subtype mediating this effect.
  • To elucidate the molecular mechanisms underlying adenosine-induced IL-10 production.

Main Methods:

  • Primary murine microglia activation and treatment with adenosine and AR agonists/antagonists.
  • Quantitative analysis of IL-10 and pro-inflammatory cytokine production (e.g., TNF-α, IL-6).
  • Adenosine receptor subtype identification using selective agonists and antagonists.
  • Investigation of molecular pathways including mRNA accumulation, promoter activity assays, CREB phosphorylation, and p38 MAPK activation.

Main Results:

  • Adenosine significantly augmented IL-10 production in activated microglia.
  • Adenosine suppressed the production of pro-inflammatory cytokines (TNF-α, IL-6, IL-12).
  • The A(2B)AR was identified as the primary receptor mediating adenosine's effect on IL-10 production.
  • Adenosine-induced IL-10 production involved transcriptional regulation via CREB activation and p38 MAPK signaling.

Conclusions:

  • Adenosine, acting through the A(2B)AR, enhances IL-10 production in activated microglia.
  • This effect is mediated by transcriptional upregulation of IL-10 involving CREB and p38 MAPK pathways.
  • Adenosine's dual action of increasing IL-10 while decreasing pro-inflammatory cytokines suggests a potent immunomodulatory role in the brain.

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...